They are not FDA-approved drugs and have not completed full clinical trial programs
The approval validated years of preclinical research and opened the door for subsequent generations of GLP-1 drugs with improved efficacy and convenience profiles
Frandsen CS, Dejgaard TF, Holst JJ, Andersen HU, Thorsteinsson B, Madsbad S (2015) Twelve-week treatment with liraglutide as add-on to insulin in normal-weight patients with poorly controlled type 1 diabetes: a randomized, placebo-controlled, double-blind parallel study
Side Effects: As per clinical studies, side effects of any supplement are closely linked to the dosage you would be consuming
Sha, J.Y
Patent intelligence tools, including those provided by DrugPatentWatch, now need to answer a different question: not just when does exclusivity expire, but what is the viable cost-plus entry price for this molecule, and how does that price compare to current protected pricing